前收市價 | 0.0300 |
開市 | 0.0500 |
買盤 | 0.0000 |
賣出價 | 0.0500 |
拍板 | 1.50 |
到期日 | 2024-07-19 |
今日波幅 | 0.0300 - 0.0500 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 218 |
bluebird (BLUE) beats sales estimates in the first quarter on increased Zynteglo product revenues. The company is on track with the ongoing launch of its gene therapies.
Who wins this face-to-face between two beaten-down biotechs?